Novel Risk Factors for Acute Coronary Syndromes and Emerging Therapies

Abstract Acute coronary syndromes represent not merely disrupted atherosclerotic plaques or luminal stenoses but rather a complex clinical syndrome. The traditional conception of pathogenesis and management of ACS has been challenged by numerous recent landmark ACS trials. Current prognostication mo...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cardiology Vol. 220; pp. 815 - 824
Main Authors Tong, David C, Wilson, Andrew M, Layland, Jamie
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ireland Ltd 01.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Acute coronary syndromes represent not merely disrupted atherosclerotic plaques or luminal stenoses but rather a complex clinical syndrome. The traditional conception of pathogenesis and management of ACS has been challenged by numerous recent landmark ACS trials. Current prognostication models lack clinical precision and can be challenging to the clinicians in tailoring management strategies for individual patients. In this review we summarise the emerging evidence of novel risk factors (plaque phenotype, coronary blood flow, endothelial dysfunction, microvascular dysfunction, and inflammation) in predicting future events and outcomes in ACS population. As the search for miracle cure for ischemic heart disease continues, one is hopeful that emerging therapeutic approaches targeting these novel risk factors will improve long-term outcomes of ACS.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2016.06.148